DCM
CRBP icon

Driehaus Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Driehaus Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
+38,977
New +$369K ﹤0.01% 350
2024
Q4 		– Sell
-127,787
Closed -$2.64M – 401
2024
Q3 		$2.64M Buy
127,787
+64,728
+103% +$3.31M 0.02% 294
2024
Q2 		$2.85M Hold
63,059
– – 0.03% 281
2024
Q1 		$2.47M Buy
+63,059
New +$1.55M 0.02% 297

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Driehaus Capital Management's CRBP Position: Q2 2026 in Review

Driehaus Capital Management opened a new position in Corbus Pharmaceuticals (CRBP) in Q2 2026: 38,977 shares worth $366K. The stake represents ﹤0.01% of the portfolio and ranks #350 among its holdings. This is a return to the name: Driehaus Capital Management previously reported a position in CRBP as recently as Q3 2024.

Driehaus Capital Management first reported a position in CRBP in Q1 2024 and has held it in 4 quarters since. The position peaked at $2.85M in Q2 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Driehaus Capital Management held 38,977 shares of Corbus Pharmaceuticals worth $366K as of Q2 2026.
  • Corbus Pharmaceuticals was a new Driehaus Capital Management position in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Driehaus Capital Management's portfolio in Q2 2026, its #350 holding.
  • Driehaus Capital Management first reported a position in Corbus Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • Driehaus Capital Management's Corbus Pharmaceuticals position peaked at $2.85M in Q2 2024.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.